(Q43244627)
Statements
Phase I clinical trial to determine maximum tolerated dose of oral albendazole in patients with advanced cancer (English)
Peter Galettis
Mohammad H Pourgholami
Michael Szwajcer
Winston Liauw
Jonathan Seef
1 February 2010